pentobarbital will decrease the extent or result of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Use of different treatment options is strongly suggested when linagliptin is usually to be administered with a CYP3A4 inducerpentobarbital will lower the level or outcome of bortezomib by influencing hepatic/i